|
EXOC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3553000000055E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01529999996242E-06 |
| Normal-vs-Stage2 |
3.036900E-03 |
| Normal-vs-Stage3 |
3.71279999999974E-06 |
| Normal-vs-Stage4 |
5.14679999730205E-08 |
| Stage1-vs-Stage2 |
4.922600E-01 |
| Stage1-vs-Stage3 |
4.959400E-01 |
| Stage1-vs-Stage4 |
2.876500E-02 |
| Stage2-vs-Stage3 |
3.045600E-01 |
| Stage2-vs-Stage4 |
3.980400E-02 |
| Stage3-vs-Stage4 |
1.844180E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25459999944511E-07 |
| Normal-vs-AfricanAmerican |
1.470200E-02 |
| Normal-vs-Asian |
4.23360000001427E-06 |
| Caucasian-vs-AfricanAmerican |
3.773600E-01 |
| Caucasian-vs-Asian |
5.080200E-01 |
| AfricanAmerican-vs-Asian |
2.027400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84139999809463E-08 |
| Normal-vs-Female |
1.54510000005548E-06 |
| Male-vs-Female |
7.158000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.9264999999975E-05 |
| Normal-vs-Age(41-60Yrs) |
3.53579999723408E-08 |
| Normal-vs-Age(61-80Yrs) |
1.67638999999387E-05 |
| Normal-vs-Age(81-100Yrs) |
5.438000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.159020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.517200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.348600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.492400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.662800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.834200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.831800E-01 |
| Classical-VS-Follicular |
8.706000E-01 |
| Classical-VS-Other |
1.868380E-01 |
| Classical-VS-Normal |
8.1739000001857E-07 |
| Tall-VS-Follicular |
9.035800E-01 |
| Tall-VS-Other |
2.689600E-01 |
| Tall-VS-Normal |
1.102740E-03 |
| Follicular-VS-Other |
3.005800E-01 |
| Follicular-VS-Normal |
2.208800E-04 |
| Other-VS-Normal |
3.283500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64219999990267E-07 |
| Normal-vs-N1 |
7.76120000045566E-07 |
| N0-vs-N1 |
3.017200E-01 |
|
|
